83 related articles for article (PubMed ID: 25375676)
1. Combined experimental and bioinformatics analysis for the prediction and identification of VHR/DUSP3 nuclear targets related to DNA damage and repair.
Forti FL
Integr Biol (Camb); 2015 Jan; 7(1):73-89. PubMed ID: 25375676
[TBL] [Abstract][Full Text] [Related]
2. Proteomic, cellular, and network analyses reveal new DUSP3 interactions with nucleolar proteins in HeLa cells.
Panico K; Forti FL
J Proteome Res; 2013 Dec; 12(12):5851-66. PubMed ID: 24245651
[TBL] [Abstract][Full Text] [Related]
3. VHR/DUSP3 phosphatase: structure, function and regulation.
Pavic K; Duan G; Köhn M
FEBS J; 2015 May; 282(10):1871-90. PubMed ID: 25757426
[TBL] [Abstract][Full Text] [Related]
4. DUSP3/VHR: A Druggable Dual Phosphatase for Human Diseases.
Monteiro LF; Ferruzo PYM; Russo LC; Farias JO; Forti FL
Rev Physiol Biochem Pharmacol; 2019; 176():1-35. PubMed ID: 30069819
[TBL] [Abstract][Full Text] [Related]
5. Loss of DUSP3 activity radiosensitizes human tumor cell lines via attenuation of DNA repair pathways.
Torres TEP; Russo LC; Santos A; Marques GR; Magalhaes YT; Tabassum S; Forti FL
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1879-1894. PubMed ID: 28389334
[TBL] [Abstract][Full Text] [Related]
6. VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates.
Chen L; Montserat J; Lawrence DS; Zhang ZY
Biochemistry; 1996 Jul; 35(29):9349-54. PubMed ID: 8755712
[TBL] [Abstract][Full Text] [Related]
7. Identification of a potent inhibitor of human dual-specific phosphatase, VHR, from computer-aided and NMR-based screening to cellular effects.
Shi Z; Tabassum S; Jiang W; Zhang J; Mathur S; Wu J; Shi Y
Chembiochem; 2007 Nov; 8(17):2092-9. PubMed ID: 17933004
[TBL] [Abstract][Full Text] [Related]
8. Specificity profiling of dual specificity phosphatase vaccinia VH1-related (VHR) reveals two distinct substrate binding modes.
Luechapanichkul R; Chen X; Taha HA; Vyas S; Guan X; Freitas MA; Hadad CM; Pei D
J Biol Chem; 2013 Mar; 288(9):6498-510. PubMed ID: 23322772
[TBL] [Abstract][Full Text] [Related]
9. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
[TBL] [Abstract][Full Text] [Related]
10. Reduced levels of Dusp3/Vhr phosphatase impair normal spindle bipolarity in an Erk1/2 activity-dependent manner.
Tambe MB; Narvi E; Kallio M
FEBS Lett; 2016 Aug; 590(16):2757-67. PubMed ID: 27423135
[TBL] [Abstract][Full Text] [Related]
11. UV Radiation-induced Impairment of Cellular Morphology and Motility is Enhanced by DUSP3/VHR Loss and FAK Activation.
Pereira NR; Russo LC; Forti FL
Cell Biochem Biophys; 2021 Jun; 79(2):261-269. PubMed ID: 33479884
[TBL] [Abstract][Full Text] [Related]
12. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
[TBL] [Abstract][Full Text] [Related]
13. Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence.
Rahmouni S; Cerignoli F; Alonso A; Tsutji T; Henkens R; Zhu C; Louis-dit-Sully C; Moutschen M; Jiang W; Mustelin T
Nat Cell Biol; 2006 May; 8(5):524-31. PubMed ID: 16604064
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.
Owens DM; Keyse SM
Oncogene; 2007 May; 26(22):3203-13. PubMed ID: 17496916
[TBL] [Abstract][Full Text] [Related]
15. DUSP3 modulates IRES-dependent translation of mRNAs through dephosphorylation of the HNRNPC protein in cells under genotoxic stimulus.
Ferruzo PYM; Boell VK; Russo LC; Oliveira CC; Forti FL
Biol Cell; 2024 May; 116(5):e2300128. PubMed ID: 38538536
[TBL] [Abstract][Full Text] [Related]
16. DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase.
Amand M; Erpicum C; Bajou K; Cerignoli F; Blacher S; Martin M; Dequiedt F; Drion P; Singh P; Zurashvili T; Vandereyken M; Musumeci L; Mustelin T; Moutschen M; Gilles C; Noel A; Rahmouni S
Mol Cancer; 2014 May; 13():108. PubMed ID: 24886454
[TBL] [Abstract][Full Text] [Related]
17. Unnatural amino acid mutagenesis reveals dimerization as a negative regulatory mechanism of VHR's phosphatase activity.
Pavic K; Rios P; Dzeyk K; Koehler C; Lemke EA; Köhn M
ACS Chem Biol; 2014 Jul; 9(7):1451-9. PubMed ID: 24798147
[TBL] [Abstract][Full Text] [Related]
18. Diverse physiological functions for dual-specificity MAP kinase phosphatases.
Dickinson RJ; Keyse SM
J Cell Sci; 2006 Nov; 119(Pt 22):4607-15. PubMed ID: 17093265
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the recognition of a bisphosphorylated MAP kinase peptide by human VHR protein Phosphatase.
Schumacher MA; Todd JL; Rice AE; Tanner KG; Denu JM
Biochemistry; 2002 Mar; 41(9):3009-17. PubMed ID: 11863439
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: selective tyrosine dephosphorylation of interferon-activated nuclear STAT5 by the VHR phosphatase.
Hoyt R; Zhu W; Cerignoli F; Alonso A; Mustelin T; David M
J Immunol; 2007 Sep; 179(6):3402-6. PubMed ID: 17785772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
